UNSPSC 51151504: Pilocarpine

This classification denotes a cholinergic agonist with the molecular formula C11H16N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 01MI4Q9DI3, chemically known as 2(3h)-furanone, 3-ethyldihydro-4-((1-methyl-1h-imidazol-5-yl)methyl)-, (3s-cis)- but generally known as pilocarpine, which bears US NIH Compound Identifier 5910. European Medicines Agency schedules Pilocarpine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03818MIG.

UNSPSC 51151504 Pilocarpine, a Commodity code, shows minimal recent state and local procurement activity aligned with the nominal pharmaceutical product. The two recent opportunities tagged under this code involve naloxone/drug deactivation systems and a Texas Health and Human Services Commission pharmacy benefit initiative — neither of which concerns pilocarpine specifically. Seminole County, Florida conducted an IFB (Solicitation IFB60459723LAS, posted June 30, 2026, due July 26, 2023) to procure 1,900 units of naloxone and 800 safe drug deactivation systems annually through quarterly deliveries, with requirements for E-Verify compliance, drug-free workplace certification, and potential FEMA funding subject to federal environmental compliance. The Texas HHS Commission issued an RFI (HHS0017013, posted April 3, 2026, due April 3, 2026) soliciting vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program, seeking information on direct contracting capacity with self-insured employers and health plans outside traditional pharmacy benefit manager and group purchasing organization channels. The code shows little relevant recent activity tied to pilocarpine as a pharmaceutical commodity; the tagged opportunities reflect broader state and local health procurement for emergency response pharmaceuticals and pharmacy benefit program innovation rather than pilocarpine acquisition specifically.

Geographic activity is concentrated in Florida and Texas based on the recent record, though the Texas opportunity is exploratory and does not commit to formal procurement. No other states appear in the supporting opportunities. The mismatch between the code's nominal scope and the actual work being solicited suggests this code does not capture pilocarpine purchasing activity at the state and local level, or that such activity is sparse and not regularly tagged to this commodity code.